glp 1 agonists vs sglt2 inhibitors Cardiorenal Protection: Potential of and GLP-1 Receptor in the Treatment of Type 2 Diabetes | Diabetes Therapy Role of GLP-1 Agonists &

Effect of GLP-1RA treatment on adhesion molecules and monocyte chemoattractant protein-1 in diabetic patients with atherosclerosis

For those with obesity or type 2 diabetes, this number jumps dramatically to over 50% 18

GLP-1-related antihyperglycemic medication use is associated with shorter survival in patients with amyotrophic lateral sclerosis and diabetes mellitus (P11-11.032) Neurology

When given to DIO mice, both peptides led to significant weight reduction, improved glucose tolerance, increased energy expenditure, and reductions in plasma cholesterol and liver steatosis

Biological actions and therapeutic potential of the glucagon-like peptides

Ultimately, the definitive role of GLP-1 RAs as an anticancer agent pivot on launching large-scale, randomized controlled trials focused explicitly on the primary prevention of HCC in high-risk patients with advanced SLD of all major etiologies